Direct questions deserve direct answers.

Jumo Health is a Patient Experience Organization that makes patient readiness measurable, actionable, and governable across clinical trial recruitment, enrollment, retention, and completion.

A Patient Experience Organization connects behavioral science, health literacy, human-centered design, data intelligence, and execution around whether patients are prepared to advance, participate, and complete. It creates operational ownership for readiness.

Patient readiness is the degree to which a patient is cognitively, emotionally, practically, and contextually prepared to participate in and complete a clinical trial. It is dynamic and can strengthen or deteriorate throughout participation.

Eligibility determines whether a patient meets clinical inclusion and exclusion criteria. Readiness determines whether participation is understood, feasible, supported, and sustainable. A patient can be medically eligible and still be unprepared for the realities of the protocol.

Engagement measures activity such as opens, clicks, views, responses, or portal use. Readiness measures whether understanding, feasibility, motivation, and support have changed enough for participation to hold.

Jumo evaluates structural friction such as transportation and scheduling, cognitive friction such as comprehension and health literacy, and behavioral friction such as fear, trust, motivation, and decisional conflict.

CORE is Jumo Health's readiness education system. It translates protocol complexity into the practical, behaviorally structured education patients, caregivers, families, and sites need before and during participation.

CORE begins with the specific protocol, patient population, burden profile, decision points, and likely readiness friction. Education is designed to address the conditions of that study rather than relying on a generic disease template.

CORE can produce patient, caregiver, HCP, and site-facing education across the trial lifecycle. The format is selected because it closes a defined readiness gap, not because it appears on a standard asset menu.

CORE treats caregivers as a readiness variable. It identifies their decision role, burden, practical responsibilities, information needs, and influence on whether participation remains feasible.

CORE uses a modular architecture so the affected educational components can be updated without rebuilding the entire readiness experience. This preserves what remains accurate while correcting what changed.

Yes. CORE is a standalone readiness education system. It can also serve as the education foundation within a PRISM deployment.

PRISM is Jumo Health's Patient Readiness and Intelligence System. It identifies eligible patients, assesses readiness, prioritizes advancement, orchestrates education and support, coordinates site handoff, and monitors completion risk.

Most AI recruitment tools improve identification, matching, targeting, or outreach efficiency. PRISM connects those capabilities to readiness assessment, behavioral diagnosis, adaptive intervention, governed advancement, site handoff, and completion-risk monitoring.

Depending on the study, PRISM can work with protocol metadata, claims, EMR or EHR, lab, genetic, site, HCP, social-determinant, behavioral, geographic, access, and patient-interaction signals.

No. Sites retain clinical responsibility and CROs retain their operational roles. PRISM moves preventable education, expectation-setting, friction detection, and readiness work upstream so sites and study teams can focus on clinical execution.

PRISM may prevent an unprepared patient from advancing prematurely. That is different from slowing the trial. Moving unreadiness faster creates failed screens, no-shows, site rework, early withdrawal, and rescue requirements.

PRISM evaluates changing readiness signals such as burden accumulation, comprehension decay, expectation drift, disengagement, caregiver instability, and practical feasibility while there is still time to intervene.

No. PRISM supports patient readiness, education, progression, and coordination. It does not diagnose, prescribe, determine treatment, or replace the clinical authority of investigators and sites.

Yes. CORE and PRISM can each operate independently. Together, CORE supplies the readiness education foundation while PRISM measures and governs progression throughout participation.

CORE creates protocol-derived readiness education. PRISM identifies when a patient needs education or support, governs the next action, and monitors whether readiness changes. One creates the readiness foundation; the other protects progression.

Start with CORE when the immediate need is stronger education, expectation alignment, caregiver preparation, or site support. Start with PRISM when the need includes identification, prioritization, orchestration, monitoring, and portfolio-level readiness intelligence.

Jumo begins by reviewing the protocol, population, site conditions, burden profile, and likely readiness friction. That analysis defines the appropriate CORE, PRISM, or combined deployment.

No. Jumo is designed to work with sponsor, CRO, site, and technology infrastructure. Integration requirements depend on the study, available data, workflow, and selected capabilities.

Requirements are evaluated against the specific study, data sources, jurisdictions, sponsor policies, and patient-facing workflows. Current security documentation, data-handling details, and governance controls are provided during evaluation.

Jumo is designed to support stronger patient advancement, lower preventable screen failure and dropout, better-prepared site handoffs, reduced site rework, more stable retention, greater forecast confidence, and improved cost per completer.

Cost per lead measures how cheaply a patient enters the funnel. Cost per completer reflects the full cost of productive participation, including screen failure, dropout, replacement recruitment, site rework, and timeline recovery.

Recruitment partners typically optimize reach, response, referral, or enrollment. PRISM governs whether patients are prepared to advance and whether participation remains sustainable after the referral or enrollment milestone.

Readiness changes where resources are applied. It moves effort upstream to prevent screen failure, site rework, early withdrawal, rescue recruitment, and timeline recovery. The relevant comparison is the cost of prevention versus the existing cost of unreadiness.

No. Clinical trial completion is affected by clinical, personal, operational, and external conditions. Jumo is designed to identify risk earlier, improve preparation, support better decisions, and increase the probability of durable participation.

Relevant examples, evidence, methodologies, and approved case-study materials can be discussed during evaluation based on the therapeutic area, study design, and requested capability.